Globus Medical, Inc. (FRA:GM0N)

Globus Medical Statistics

Total Valuation

Globus Medical has a market cap or net worth of EUR 10.51 billion. The enterprise value is 10.26 billion.

Market Cap	10.51B
Enterprise Value	10.26B

Important Dates

The next estimated earnings date is Wednesday, February 18, 2026.

Earnings Date	Feb 18, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	111.41M
Shares Outstanding	n/a
Shares Change (YoY)	+1.31%
Shares Change (QoQ)	-0.81%
Owned by Insiders (%)	17.22%
Owned by Institutions (%)	90.23%
Float	110.51M

Valuation Ratios

The trailing PE ratio is 29.09 and the forward PE ratio is 22.06.

PE Ratio	29.09
Forward PE	22.06
PS Ratio	4.45
PB Ratio	2.80
P/TBV Ratio	5.63
P/FCF Ratio	21.27
P/OCF Ratio	17.24
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.48, with an EV/FCF ratio of 20.77.

EV / Earnings	28.41
EV / Sales	4.30
EV / EBITDA	14.48
EV / EBIT	22.71
EV / FCF	20.77

Financial Position

The company has a current ratio of 4.13, with a Debt / Equity ratio of 0.03.

Current Ratio	4.13
Quick Ratio	2.31
Debt / Equity	0.03
Debt / EBITDA	0.15
Debt / FCF	0.21
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 10.01% and return on invested capital (ROIC) is 7.18%.

Return on Equity (ROE)	10.01%
Return on Assets (ROA)	6.43%
Return on Invested Capital (ROIC)	7.18%
Return on Capital Employed (ROCE)	11.32%
Revenue Per Employee	445,416
Profits Per Employee	68,148
Employee Count	5,300
Asset Turnover	0.54
Inventory Turnover	1.21

Taxes

In the past 12 months, Globus Medical has paid 31.30 million in taxes.

Income Tax	31.30M
Effective Tax Rate	7.97%

Stock Price Statistics

The stock price has decreased by -1.88% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-1.88%
50-Day Moving Average	57.90
200-Day Moving Average	56.76
Relative Strength Index (RSI)	81.17
Average Volume (20 Days)	9

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.89

Income Statement

In the last 12 months, Globus Medical had revenue of EUR 2.36 billion and earned 361.19 million in profits. Earnings per share was 2.62.

Revenue	2.36B
Gross Profit	1.59B
Operating Income	446.55M
Pretax Income	392.49M
Net Income	361.19M
EBITDA	681.53M
EBIT	446.55M
Earnings Per Share (EPS)	2.62

Balance Sheet

The company has 332.84 million in cash and 102.37 million in debt, giving a net cash position of 244.69 million.

Cash & Cash Equivalents	332.84M
Total Debt	102.37M
Net Cash	244.69M
Net Cash Per Share	n/a
Equity (Book Value)	3.75B
Book Value Per Share	27.85
Working Capital	1.24B

Cash Flow

In the last 12 months, operating cash flow was 609.56 million and capital expenditures -115.57 million, giving a free cash flow of 494.00 million.

Operating Cash Flow	609.56M
Capital Expenditures	-115.57M
Free Cash Flow	494.00M
FCF Per Share	n/a

Margins

Gross margin is 67.51%, with operating and profit margins of 18.92% and 15.30%.

Gross Margin	67.51%
Operating Margin	18.92%
Pretax Margin	16.63%
Profit Margin	15.30%
EBITDA Margin	28.87%
EBIT Margin	18.92%
FCF Margin	20.93%

Dividends & Yields

Globus Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.31%
Shareholder Yield	-1.31%
Earnings Yield	3.44%
FCF Yield	4.70%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Globus Medical has an Altman Z-Score of 9.87 and a Piotroski F-Score of 7.

Altman Z-Score	9.87
Piotroski F-Score	7